TrialBlood2010

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.

Peter G Maslak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.